KalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet needs.
|Data provided by Nasdaq. Minimum 15 minutes delayed. |
View Attributions and Sources
September 14, 2017KalVista Pharmaceuticals Reports Fiscal First Quarter ResultsMore News
There are currently no events scheduled.More Events